Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain

Experimental Neurology

Volumn 225, Issue 1, 2010, Pages 60-73

  Dobbertin, Alexandre ^a,c   Czvitkovich, Stefan ^b   Theocharidis, Ursula ^a   Garwood, Jeremy ^a   Andrews, Melissa R ^b   Properzi, Francesca ^b   Lin, Rachel ^b   Fawcett, James W ^b   Faissner, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSERM   (France)

Author keywords

Astrocyte; Cerebral cortex; CNS injury; Cytokine; Extracellular matrix; Fibronectin type III domain; Glial scar; Regeneration; Tenascin; TGF 1

Indexed keywords

CYTOKINE; FIBRONECTIN; FIBRONECTIN 3; RNA; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CONTACTIN; ISOPROTEIN; NERVE CELL ADHESION MOLECULE;

ADULT ANIMAL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN NERVE CELL; BRAIN TISSUE; CELL ADHESION; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NERVE FIBER; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DISEASE MODEL; GENETICS; METABOLISM; NERVE REGENERATION; NEWBORN; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT;

ALTERNATIVE SPLICING; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN INJURIES; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; CONTACTINS; DISEASE MODELS, ANIMAL; FEMALE; FIBRONECTINS; NERVE REGENERATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; TENASCIN;

EID: 77955656444     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.04.019     Document Type: Article

References (59)

1. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 2000, 20:2427-2438.
2. Bartsch S., Bartsch U., Dorries U., Faissner A., Weller A., Ekblom P., Schachner M. Expression of tenascin in the developing and adult cerebellar cortex. J. Neurosci. 1992, 12:736-749.
3. Bartsch U. The extracellular matrix tenascin-C: expression in vivo and functional characterization in vitro. Prog. Neurobiol. 1996, 49:145-168.
4. Brodkey J.A., Laywell E.D., O'Brien T.F., Faissner A., Stefansson K., Dorries H.U., Schachner M., Steindler D.A. Focal brain injury and upregulation of a developmentally regulated extracellular matrix. J. Neurosurg. 1995, 82:106-112.
5. Chiquet-Ehrismann R., Chiquet M. Tenascins: regulation and putative functions during pathological stress. J. Pathol. 2003, 200:488-499.
6. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal. Biochem. 1987, 162:156-159.
7. Deller T., Haas C.A., Naumann T., Joester A., Faissner A., Frotscher M. Up-regulation of astrocyte-derived tenascin-C correlates with neurite outgrowth in the rat dentate gyrus after unilateral entorhinal cortex lesion. Neuroscience 1997, 81:829-846.
8. Derr L.B., Chiquet-Ehrismann R., Gandour-Edwards R., Spence J., Tucker R.P. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation 1997, 62:71-82.
9. Dobbertin A., Rhodes K.E., Garwood J., Properzi F., Heck N., Rogers J.H., Fawcett J.W., Faissner A. Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol. Cell. Neurosci. 2003, 24:951-971.
10. Dörries U., Taylor J., Xiao Z., Lochter A., Montag D., Schachner M. Distinct effects of recombinant tenascin-C domains on neuronal cell adhesion, growth cone guidance, and neuronal polarity. J. Neurosci. Res. 1996, 43:420-438.
11. Faissner A. The tenascin gene family in axon growth and guidance. Cell Tissue Res. 1997, 290:331-341.
12. Faissner A., Kruse J. J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 1990, 5:627-637.
13. Faissner A., Steindler D. Boundaries and inhibitory molecules in developing neural tissues. Glia 1995, 13:233-254.
14. Flanders K.C., Ren R.F., Lippa C.F. Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 1998, 54:71-85.
15. Garcion E., Faissner A., French-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 2001, 128:2485-2496.
16. Garwood J., Rigato F., Heck N., Faissner A. Tenascin glycoproteins and the complementary ligand DSD-1-PG/phosphacan-structuring the neural extracellular matrix during development and repair. Restor. Neurol. Neurosci. 2001, 19:51-64.
17. Garwood J., Garcion E., Dobbertin A., Heck N., Calco V., ffrench-Constant C., Faissner A. The extracellular matrix glycoprotein tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur. J. Neurosci. 2004, 20:2524-2540.
18. Gates M.A., Thomas L.B., Howard E.M., Laywell E.D., Sajin B., Faissner A., Götz B., Silver J., Steindler D.A. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J. Comp. Neurol. 1995, 361:249-266.
19. Götz B., Scholze A., Clement A., Joester A., Schuette K., Wigger F., Frank R., Spiess E., Ekblom P., Faissner A. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J. Cell. Biol. 1996, 132:681-699.
20. Götz M., Bolz J., Joester A., Faissner A. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur. J. Neurosci. 1997, 9:496-506.
21. Gulcher J.R., Nies D.E., Marton L.S., Stefansson K. An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:1588-1592.
22. Hirsch S., Bähr M. Immunocytochemical characterization of reactive optic nerve astrocytes and meningeal cells. Glia 1999, 26:36-46.
23. Hoke A., Silver J. Heterogeneity among astrocytes in reactive gliosis. Perspect. Dev. Neurobiol. 1994, 2:269-274.
24. Husmann K., Faissner A., Schachner M. Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J. Cell. Biol. 1992, 116:1475-1486.
25. Joester A., Faissner A. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J. Biol. Chem. 1999, 274:17144-17151.
26. Joester A., Faissner A. The structure and function of tenascins in the nervous system. Matrix Biol. 2001, 20:13-22.
27. Jones P.L., Jones F.S. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 2000, 19:581-596.
28. Junier M.P. What role(s) for TGF?α in the central nervous system?. Prog. Neurobiol. 2000, 62:443-473.
29. Laywell E.D., Dörries U., Bartsch U., Faissner A., Schachner M., Steindler D. Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:2634-2638.
30. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 2001, 24:39-47.
31. Liu H.Y., Nur-E-Kamal A., Schachner M., Meiners S. Neurite guidance by the FnC repeat of human tenascin-C: neurite attraction vs. neurite retention. Eur. J. Neurosci. 2005, 22:1863-1872.
32. Lochter A., Vaughan L., Kaploni A., Prochiantz A., Schachner M., Faissner A. J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J. Cell. Biol. 1991, 113:1159-1171.
33. Logan A., Frautschy S.A., Gonzales A.M., Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J. Neurosci. 1992, 12:3828-3837.
34. Mackie E.J., Abraham L.A., Taylor S.L., Tucker R.P., Murphy L.I. Regulation of tenascin-C expression in bone cells by transforming growth factor-beta. Bone 1998, 22:301-307.
35. Mahler M., Ben-Ari Y., Represa A. Differential expression of fibronectin, tenascin-C and NCAMs in cultured hippocampal astrocytes activated by kainate, bacterial lipopolysaccharide or basic fibroblast growth factor. Brain Res. 1997, 775:63-73.
36. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 1991, 11:3398-3411.
37. Meiners S., Geller H.M. Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol. Cell. Neurosci. 1997, 10:100-116.
38. Meiners S., Marone M., Rittenhouse J.L., Geller H.M. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev. Biol. 1993, 160:480-493.
39. Meiners S., Mercado M.L.T., Nur-e-Kamal M.S.A., Geller H.M. Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. J. Neurosci. 1999, 19:8443-8453.
40. Meiners S., Nur-e-Kamal M.S.A., Mercado M.L.T. Identification of a neurite outgrowth-promoting motif within the alternatively spliced region of human tenascin-C. J. Neurosci. 2001, 21:7215-7225.
41. Mercado M.L., Nur-e-Kamal A., Liu H.Y., Gross S.R., Movahed R., Meiners S. Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal α7β1 integrin. J. Neurosci. 2004, 24:238-247.
42. Milev P., Fischer D., Haring M., Schulthess T., Margolis R.K., Chiquet-Ehrismann R., Margolis R.U. The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta. J. Biol. Chem. 1997, 272:15501-15509.
43. Nakic M., Mitrovic N., Sperk G., Schachner M. Kainic acid activates transient expression of tenascin-C in the adult rat hippocampus. J. Neurosci. Res. 1996, 44:355-362.
44. Niquet J., Jorquera I., Faissner A., Ben-Ari Y., Represa A. Gliosis and axonal sprouting in the hippocampus of epileptic rats are associated with an increase of tenascin-C immunoreactivity. J. Neurocytol. 1995, 24:611-624.
45. Prieto A.L., Jones F.S., Cunningham B.A., Crossin K.L., Edelman G.M. Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J. Cell. Biol. 1990, 111:685-698.
46. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204:33-48.
47. Richardson R.M., Sun D., Bullock M.R. Neurogenesis after traumatic brain injury. Neurosurg. Clin. N. Am. 2007, 1:169-181.
48. Rigato F., Garwood J., Calco V., Heck N., Faivre-Sarrailh C., Faissner A. Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/Contactin. J. Neurosci. 2002, 22:6596-6609.
49. Smith G.M., Hale J.H. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J. Neurosci. 1997, 17:9624-9633.
50. Smith C., Berry M., Clarke W.E., Logan A. Differential expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 in a scarring and nonscarring model of CNS injury in the rat. Eur. J. Neurosci. 2001, 13:443-456.
51. Suzuki S., Li A.J., Ikemoto M., Imamura T. Expression of tenascin-C long isoforms is induced in the hypothalamus by FGF-1. Neuroreport 2002, 13:1041-1045.
52. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71:427-444.
53. Treloar H.B., Ray A., Dinglasan L.A., Schachner M., Greer C.A. Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J. Neurosci. 2009, 29:9405-9416.
54. Tucker R.P. The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 1993, 117:347-358.
55. Tucker R.P., Hammarback J.A., Jenrath D.A., Mackie E.J., Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J. Cell Sci. 1993, 104:69-76.
56. von Holst A., Egbers U., Prochiantz A., Faissner A. Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6. J. Biol. Chem. 2007, 282:9172-9181.
57. Werner A., Willem M., Jones L.L., Kreutzberg G.W., Mayer U., Raivich G. Impaired axonal regeneration in alpha7 integrin-deficient mice. J. Neurosci. 2000, 20:1822-1830.
58. Zhang Y., Winterbottom J.K., Schachner M., Lieberman A.R., Anderson P.N. Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J. Neurosci. Res. 1997, 49:433-450.
59. Zhao Y., Young S.L. TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am. J. Physiol. 1995, 268:L173-L180.